| Powder free. Non-sterile. Textured fingertips. Tested for use with 15 chemotherapy drugs. Quality alternative to latex gloves. The ASTM has established minimum quality standards for the manufacture of safe and effective infection control devices. This product exceeds ASTM minimum standards. This exam glove is intended to protect the wearer and/or the subject from contamination. Meets ASTM D6978 for resistance to permeation by chemotherapy drugs. Meets ASTM D6319 standard specification for nitrile exam gloves. Tested for viral penetration per ASTM F1671. Chemotherapy Drug Permeation (Average breakthrough detection time in minutes): Carmustine (BCNU) 3.3 mg/mL (3,300 ppm) - not recommended for use Cisplatin 1.0 mg/mL (1,000 ppm) >240 Cyclophosphamide (Cytoxan) 20.0 mg/mL (20,000 ppm) >240 Cytarabine 100 mg/mL (100,000 ppm) >240 Dacarbazine (DTIC) 10.0 mg/mL (10,000 ppm) >240 Doxorubicin Hydrochloride 2.0 mg/mL (2,000 ppm) >240 Etoposide (Toposar) 20.0 mg/mL (20,000 ppm) >240 Fluorouracil 50.0 mg/mL (50,000 ppm) >240 Ifosfamide 50.0 mg/mL (50,000 ppm) >240 Methotrexate 25 mg/mL (25,000 ppm) >240 Mitomycin C 0.5 mg/mL (500 ppm) >240 Mitoxantrone 2.0 mg/mL (2,000 ppm) >240 Paclitaxel (Taxol) 6.0 mg/mL (6,000 ppm) >240 Thiotepa 10.0 mg/mL (10,000 ppm) not recommended for use Vincristine Sulfate 1.0 mg/mL (1,000 ppm) >240. Not manufactured with natural rubber latex. | |